Who owns Revance Therapeutics?
- CUSIP Number: 761330959
Tip: Access positions for across all investors
Analyze quarterly positions in Revance Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revance Therapeutics stock
Who bought or sold Revance Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Simplex Trading | 47k | $243k | -43% | Sep 2024 |
|
| Group One Trading | 39k | $200k | -24% | Sep 2024 |
|
Who sold out of Revance Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2024 | 40k | $104k |